NGM BIOPHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
NGM BIOPHARMACEUTICALS INC has filed 528 SEC EDGAR filings since 04 Feb 2008

SEC filing history

Showing 26-50 of 523 matching filings.

Per page
25
Current page
2
SC 13E3/A File 005-90978

SC TO-T/A

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13E3/A File 005-90978

SC 13E3/A

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-90978

SC 14D9/A

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-90978

SC 14D9/A

Filing date
29 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13E3/A File 005-90978

SC TO-T/A

Filing date
22 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-90978

SC 14D9/A

Filing date
22 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13E3/A File 005-90978

SC 13E3/A

Filing date
22 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 005-90978

UPLOAD filing

Filing date
19 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 005-90978

UPLOAD filing

Filing date
19 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13E3 File 005-90978

SC 13E3

Filing date
08 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-90978

SC 14D9

Filing date
08 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13E3 File 005-90978

SC TO-T

Filing date
08 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90978

AMENDMENT NO. 7

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-90978

SC14D9C

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-90978

SCHEDULE TO-C

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90978

SC 13G/A filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90978

SCHEDULE 13G/A

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .